Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. John T. TreaceFounder, Chairman & CEO | 50,00k | 177,92k | Kauf | 3,56 | 12,65M | 0,40% |
| 2026-05-26 | Mr. John T. TreaceFounder, Chairman & CEO | 115,52k | 340,59k | Kauf | 2,79 - 3,02 | 12,06M | 0,97% |
| 2026-05-12 | Mr. John T. TreaceFounder, Chairman & CEO | 153,76k | 375,51k | Kauf | 2,17 - 2,62 | 11,94M | 1,30% |
| 2026-04-17 | Mr. Mark L. HairCFO | -11,55k | 0,00 | Sale to Issuer | - | 165,31k | -6,53% |
| 2026-03-08 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -1,85k | 0,00 | Sale to Issuer | - | 161,06k | -1,14% |
| 2026-03-08 | Mr. John T. TreaceFounder, Chairman & CEO | -7,08k | 0,00 | Sale to Issuer | - | 11,79M | -0,06% |
| 2026-03-08 | Mr. Mark L. HairCFO | -4,66k | 0,00 | Sale to Issuer | - | 151,86k | -2,98% |
| 2026-03-08 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | -1,80k | 0,00 | Sale to Issuer | - | 200,76k | -0,89% |
| 2026-02-10 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | 16,88k | 17,72k | Derivative Exercise and Retained Stock | 1,05 | 195,18k | 9,46% |
| 2026-01-22 | Mr. John T. TreaceFounder, Chairman & CEO | -14,25k | 0,00 | Sale to Issuer | - | 11,76M | -0,12% |
| 2026-01-21 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | 53,50k | 38,52k | Derivative Exercise and Retained Stock | 0,72 | 178,31k | 42,87% |
| 2026-01-22 | Mr. Mark L. HairCFO | -17,04k | 0,00 | Sale to Issuer | - | 142,07k | -10,71% |
| 2026-01-22 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -9,45k | 0,00 | Sale to Issuer | - | 155,32k | -5,74% |
| 2026-01-10 | Mr. Mark L. HairCFO | -8,72k | 0,00 | Sale to Issuer | - | 112,24k | -7,21% |
| 2026-01-10 | Mr. John T. TreaceFounder, Chairman & CEO | -13,22k | 0,00 | Sale to Issuer | - | 11,74M | -0,11% |
| 2026-01-10 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -4,54k | 0,00 | Sale to Issuer | - | 132,89k | -3,31% |
| 2025-12-01 | Mr. Gaetano M. GuglielminoInsider | -22,10k | 0,00 | Sale to Issuer | - | 68,65k | -24,35% |
| 2025-10-25 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -984,00 | 0,00 | Sale to Issuer | - | 122,11k | -0,80% |
| 2025-10-24 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | -208,00 | 0,00 | Sale to Issuer | - | 89,65k | -0,23% |
| 2025-09-30 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -16,88k | 0,00 | Sale to Issuer | - | 120,60k | -12,28% |
| 2025-08-09 | Mr. Aaron J. BeruttiSVP of Commercial Excellence | -4,91k | 0,00 | Sale to Issuer | - | 23,14k | -17,50% |
| 2025-08-09 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | -9,81k | 0,00 | Sale to Issuer | - | 89,01k | -9,93% |
| 2025-08-09 | Mr. Mark L. HairCFO | -22,21k | 0,00 | Sale to Issuer | - | 97,74k | -18,52% |
| 2025-08-09 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -10,52k | 0,00 | Sale to Issuer | - | 86,05k | -10,89% |
| 2025-07-18 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | 33,44k | 24,00k | Derivative Exercise and Retained Stock | 0,72 | 58,52k | 133,29% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
